These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19159856)

  • 1. Extremely late drug-eluting stent thrombosis: 2037 days after deployment.
    Layland J; Jellis C; Whitbourn R
    Cardiovasc Revasc Med; 2009; 10(1):55-7. PubMed ID: 19159856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of biodegradable polymer-coated sirolimus-eluting stents in "real-world" practice: 18-month clinical and 9-month angiographic outcomes.
    Han Y; Jing Q; Xu B; Yang L; Liu H; Shang X; Jiang T; Li Z; Zhang H; Li H; Qiu J; Liu Y; Li Y; Chen X; Gao R;
    JACC Cardiovasc Interv; 2009 Apr; 2(4):303-9. PubMed ID: 19463441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of late stent malapposition beyond 2 years after sirolimus-eluting stent implantation.
    Ueno K; Kawamura A; Mintz GS; Weissman NJ; Jinzaki M; Okabe T; Kobayakawa N; Yamada M; Kuribayashi S; Ogawa S
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1288-9. PubMed ID: 20129559
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug-eluting stent thrombosis 1,659 days after stent deployment: case report and literature review.
    Al-Dehneh A; Virk H; Alkhouri Y; Hamdan A; Bikkina M
    Tex Heart Inst J; 2010; 37(3):343-6. PubMed ID: 20548819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Very late stent thrombosis due to DES fracture: description of a case and review of potential causes.
    Lee SW; Tam FC; Chan KK
    Catheter Cardiovasc Interv; 2011 Dec; 78(7):1101-5. PubMed ID: 21523887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does underlying plaque morphology play a role in vessel healing after drug-eluting stent implantation?
    Finn AV; Nakazawa G; Ladich E; Kolodgie FD; Virmani R
    JACC Cardiovasc Imaging; 2008 Jul; 1(4):485-8. PubMed ID: 19356471
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of vascular response after sirolimus-eluting stent implantation between patients with unstable and stable angina pectoris: a serial optical coherence tomography study.
    Kubo T; Imanishi T; Kitabata H; Kuroi A; Ueno S; Yamano T; Tanimoto T; Matsuo Y; Masho T; Takarada S; Tanaka A; Nakamura N; Mizukoshi M; Tomobuchi Y; Akasaka T
    JACC Cardiovasc Imaging; 2008 Jul; 1(4):475-84. PubMed ID: 19356470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of very late stent thrombosis after drug-eluting stent implantation: findings from coronary angioscopy and optical coherence tomography.
    Ikenaga H; Ishihara M; Dai K; Nakama Y; Ohtani T
    JACC Cardiovasc Imaging; 2011 Nov; 4(11):1217-9. PubMed ID: 22093273
    [No Abstract]   [Full Text] [Related]  

  • 9. Simultaneous very late stent thrombosis in multiple coronary arteries.
    Narasimhan S; Krim NR; Silverman G; Monrad ES
    Tex Heart Inst J; 2012; 39(5):630-4. PubMed ID: 23109755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary results of the hydroxyapatite nonpolymer-based sirolimus-eluting stent for the treatment of single de novo coronary lesions a first-in-human analysis of a third-generation drug-eluting stent system.
    Costa JR; Abizaid A; Costa R; Feres F; Tanajura LF; Abizaid A; Mattos LA; Staico R; Siqueira D; Sousa AG; Bonan R; Sousa JE
    JACC Cardiovasc Interv; 2008 Oct; 1(5):545-51. PubMed ID: 19463357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balancing hemorrhagic and thrombotic complications in a patient with a very late paclitaxel-eluting stent thrombosis: a clinical case report.
    Esposito G; Cassese S; Gargiulo G; Sannino A; Schiattarella GG; Piscione F; Chiariello M
    J Cardiovasc Med (Hagerstown); 2011 May; 12(5):366-9. PubMed ID: 20407382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased serum vWF and sVCAM-1 levels are associated with late or very late angiographic stent thrombosis after sirolimus-eluting stent implantation.
    Jin C; Lu L; Zhu ZB; Zhang RY; Zhang Q; Du R; Ding FH; Chen QJ; Shen WF
    Coron Artery Dis; 2010 Aug; 21(5):273-7. PubMed ID: 20508517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PASEO (PaclitAxel or Sirolimus-Eluting Stent Versus Bare Metal Stent in Primary Angioplasty) Randomized Trial.
    Di Lorenzo E; De Luca G; Sauro R; Varricchio A; Capasso M; Lanzillo T; Manganelli F; Mariello C; Siano F; Pagliuca MR; Stanco G; Rosato G
    JACC Cardiovasc Interv; 2009 Jun; 2(6):515-23. PubMed ID: 19539255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptomatic abnormal vessel wall reaction after implantation of the first generation sirolimus-eluting stent: a case series.
    Mostafa AE; Richardt G; Abdel-Wahab M
    Cardiovasc Revasc Med; 2012; 13(3):196-200. PubMed ID: 22652316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term clinical and angiographic outcomes after implantation of sirolimus-eluting stents with a "modified mini-crush" technique in coronary bifurcation lesions.
    Yang HM; Tahk SJ; Woo SI; Lim HS; Choi BJ; Choi SY; Yoon MH; Park JS; Zheng M; Hwang GS; Kang SJ; Shin JH
    Catheter Cardiovasc Interv; 2009 Jul; 74(1):76-84. PubMed ID: 19360861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immediate and long-term results of treatment of complex lesions of the left anterior descending coronary artery involving a large diagonal branch with drug-eluting stents.
    Varbella F; Gagnor A; Tomassini F; Infantino V; Conte MR
    J Cardiovasc Med (Hagerstown); 2008 Nov; 9(11):1088-94. PubMed ID: 18852578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of 2.5-mm sirolimus-eluting stent implantation at lower deployment pressures in very small vessels (<2.5 mm).
    Umeda H; Iwase M; Gochi T; Izawa H; Ishiki R; Inagaki H; Shimizu T; Yokota M; Murohara T
    Coron Artery Dis; 2009 Mar; 20(2):163-8. PubMed ID: 19293669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender-based evaluation of the XIENCE V everolimus-eluting coronary stent system: clinical and angiographic results from the SPIRIT III randomized trial.
    Lansky AJ; Ng VG; Mutlu H; Cristea E; Guiran JB; Midei M; Newman W; Sanz M; Sood P; Doostzadeh J; Su X; White R; Cao S; Sudhir K; Stone GW
    Catheter Cardiovasc Interv; 2009 Nov; 74(5):719-27. PubMed ID: 19530147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for drug-eluting stent treatment of bifurcation coronary artery disease in the United States: insights from the e-Cypher S.T.L.L.R.trial.
    Suzuki N; Angiolillo DJ; Tannenbaum MA; Driesman MH; Smith C; Bikkina M; Meckel CR; Morales CE; Xenopoulos NP; Coletta JE; Bezerra HG; Bass TA; Costa MA
    Catheter Cardiovasc Interv; 2009 Jun; 73(7):890-7. PubMed ID: 19455662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
    Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.